Cue BiopharmaCUE
13F holders, Q2 2025 (June 30)47holders −2
8new positions
10sold out
1famous investor
$0.68avg. 13F price*
At the end of Q2 2025, 47 institutions reported holding Cue Biopharma Inc. (CUE) in their 13F filings, down 2 from Q1 2025. 8 opened new positions and 10 sold out. The largest holders were Bleichroeder LP ($4.7M), GC Wealth Management RIA, LLC ($2.3M) and Vanguard Group Inc. ($2.2M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Cue Biopharma Inc.
- CUSIP
- 22978P106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $2.5M |
| Exits | 10 | $297K |
All 13F filers, Q1 2025 → Q2 2025: 6,811,786 shares bought and 862,747 shares sold, net +5,949,039 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| Bleichroeder LP | 1.15% | Add +36.5% | 6,819,164 | $4.7M |
| GC Wealth Management RIA, LLC | 0.19% | New | 3,331,644 | $2.3M |
| Vanguard Group Inc. | 0.00% | Add +37.6% | 3,187,346 | $2.2M |
| Geode Capital Management, LLC | 0.00% | Reduce -0.3% | 692,173 | $472K |
| Robertson Stephens Wealth Management, LLC | 0.01% | No change | 478,500 | $326K |
| BlackRock, Inc. | 0.00% | Reduce -29.3% | 449,162 | $306K |
| Bank of America Corp. | 0.00% | Add +0.1% | 324,584 | $221K |
| UBS Group AG | 0.00% | Add +377.2% | 292,583 | $200K |
| Advisory Research Inc. | 0.03% | No change | 257,225 | $176K |
| Stifel Financial Corp. | 0.00% | Reduce -3.5% | 196,556 | $134K |
| State Street Corp. | 0.00% | No change | 189,753 | $129K |
| Susquehanna International Group, LLP | 0.00% | New | 154,243 | $105K |
| Renaissance Technologies | 0.00% | Add +261.2% | 133,464 | $91K |
| Northern Trust Corp. | 0.00% | Reduce -32.6% | 132,573 | $90K |
| Angeles Wealth Management, LLC | 0.01% | New | 120,000 | $82K |
| Chicago Partners Investment Group LLC | 0.00% | Reduce -2.2% | 88,302 | $79K |
| Northwestern Mutual Wealth Management Co. | 0.00% | Add +730.0% | 83,000 | $57K |
| LPL Financial LLC | 0.00% | Add +38.4% | 59,390 | $41K |
| Sigma Planning Corp | 0.00% | Reduce -83.0% | 55,500 | $38K |
| Texas Capital Bank Wealth Management Services Inc | 0.00% | No change | 33,102 | $23K |
| Morgan Stanley | 0.00% | Add +2.6% | 29,452 | $20K |
| Navalign, LLC | 0.00% | No change | 25,000 | $17K |
| XTX Topco Ltd | 0.00% | Reduce -16.5% | 22,493 | $15K |
| Virtu Financial LLC | 0.00% | New | 20,667 | $14K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 20,000 | $14K |
| NewEdge Advisors, LLC | 0.00% | Add +684.3% | 20,000 | $14K |
| Wells Fargo & Company | 0.00% | Reduce -2.5% | 19,577 | $13K |
| Prevail Innovative Wealth Advisors, LLC | 0.00% | New | 18,987 | $13K |
| Salzhauer Michael | 0.01% | New | 16,000 | $11K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -0.2% | 14,376 | $10K |
| SeaCrest Wealth Management, LLC | 0.00% | No change | 13,000 | $9K |
| HRT Financial LP | 0.00% | New | 11,812 | $8K |
| Beacon Pointe Advisors, LLC | 0.00% | No change | 10,000 | $7K |
| JPMorgan Chase & Co. | 0.00% | Add +568.9% | 7,030 | $5K |
| Barclays PLC | 0.00% | No change | 6,029 | $4K |
| Gleason Group, Inc. | 0.00% | No change | 6,000 | $4K |
| Raymond James Financial Inc. | 0.00% | New | 3,350 | $2K |
| NFSG Corp | 0.00% | Reduce -14.3% | 3,000 | $2K |
| Golden State Wealth Management, LLC | 0.00% | No change | 2,000 | $1K |
| Tidemark, LLC | 0.00% | No change | 1,500 | $1K |
| Physician Wealth Advisors, Inc. | 0.00% | No change | 1,006 | $687 |
| BNP Paribas Financial Markets | 0.00% | No change | 715 | $488 |
| Osaic Holdings, Inc. | 0.00% | No change | 680 | $463 |
| Sunbelt Securities, Inc. | 0.00% | No change | 237 | $258 |
| MAI Capital Management | 0.00% | No change | 350 | $239 |
| Armstrong Advisory Group, Inc. | 0.00% | No change | 120 | $82 |
| IFP Advisors, Inc | 0.00% | No change | 100 | $68 |
"% of holder's portfolio" is CUE's weight in each manager's 13F, not the share of Cue Biopharma Inc. the manager owns.